The genetic association to weight management and obesity has been the subject of
scientific debate for a number of years. BodySync’s approach to genetics and weight
control is less concerned with single magic bullet “obesity genes” and more focused
on deciphering and utilizing the escalating scientific evidence of the inter-relatedness
of genetic variations most often associated with healthy weight management. To decrypt
these connections, BodySync sponsors ongoing IRB clinical studies conducted by Dr.
Michael Goran, PhD., Professor of Preventative Medicine, Biophysics and Pediatrics
at USC’s Keck School of Medicine.
Current Pilot Study
The most current pilot study has been designed to assess 60 adults between
the ages of 18 and 55. Participants are genotyped based on BodySync’s core gene
panel, which includes a robust number of genes and variants that research has shown
to have potential impact on healthy nutrition, fitness, and lifestyle. The combined
data from the participant’s genetic analysis and nutrition and lifestyle questionnaire
are used to generate a custom meal plan, nutritional supplement regimen, and exercise
plan for that participant. Health-related biomarkers, anthropometrics, and fitness
parameters will be assessed at the beginning of the study, after three weeks, and
again after 11 weeks to determine the effect of the customized program on each of
these outcomes. Of particular interest is the impact of genetically-guided nutrition
and fitness on serum lipid parameters, blood glucose, and other health and wellness
markers. Results will be measured in relation to other commercially available, standard-of-care
health promotion programs. In addition to its ongoing adult genetic nutrition and
fitness studies, BodySync and Dr. Michael Goran plan to conduct a study on childhood
obesity at USC Keck School. A 400-plus-subject retrospective analysis using a unique,
new assessment algorithm designed by BodySync, the study may lead to a better understanding
of how genetic information may be used to help combat childhood obesity and the
increasing incidence of type 2 diabetes in children.